News

Madison Pacific Properties Welcomes New Directors to Board

Madison Pacific Properties Welcomes New Directors to Board

Madison Pacific Properties Announces Board Changes

In an important announcement, Madison Pacific Properties Inc. (TSX: MPC, TSX: MPC-C.TO) has revealed changes to its Board of Directors that reflect its ongoing commitment to strong governance and leadership. The Vancouver-based real estate company is making strategic adjustments with the upcoming resignation of two long-standing board members.

Departing Directors

Mark Elliott, a dedicated member of the Board, will conclude his tenure effective September 30. With over twelve years of service, Mr. Elliott has played a pivotal role in the company, also acting as Chairman of the Audit Committee for nine of those years. His insights and dedication have significantly shaped the governance and growth trajectory of Madison Pacific.

Jonathan Rees will also leave the Board on the same date, marking over six years of committed service. The company is immensely grateful to both Mr. Elliott and Mr. Rees for their invaluable contributions and leadership throughout their terms.

Welcoming New Leadership

In an effort to bolster its leadership team, Madison Pacific is pleased to appoint Alistair Duncan, Jr. and Robert Wiens as new Board members effective September 30. Both individuals bring a wealth of experience in corporate governance and strategic development, enhancing the Board's ability to navigate challenges and capitalize on opportunities in the real estate sector.

Experience of Alistair Duncan, Jr.

Alistair Duncan comes with a robust background in leadership roles. He currently serves as the President and CEO of viDA Therapeutics Inc., a Vancouver-based biotech firm. Before this, Mr. Duncan was the co-founder and President of Chromos Molecular Systems Inc., demonstrating his expertise in the biotech landscape. His prior experience as a Principal with Ernst & Young LLP further emphasizes his strong finance and strategic acumen.

Robert Wiens’s Management Expertise

Robert Wiens brings over three decades of executive management experience to the team. He has held key positions such as Chief Financial Officer at D-Wave Systems and also served as CEO of FACS Records Centre Inc. His vast experience includes being a Managing Partner at Arthur Andersen & Co.'s Vancouver office. Mr. Wiens is recognized with several professional distinctions, including membership and fellowship in the Chartered Professional Accountants of British Columbia.

Familiarity with Company Operations

Both Mr. Duncan and Mr. Wiens are well-acquainted with the business dynamics of Madison Pacific. Prior to the privatization of Metro Vancouver Properties Corp. (MVP) in 2024, they both served on its Board. This familiarity will aid in their transition and ability to contribute effectively as Directors of Madison Pacific.

Exciting Future Ahead

The Board of Madison Pacific looks forward to the strategic insights and stewardship that Mr. Duncan and Mr. Wiens will provide in this new chapter of leadership. Their appointment reflects the company's desire to continue driving growth and operational excellence within the real estate sector.

Contact Information

If you have inquiries, you can reach out to:

Mr. Dino Di Marco
President & CEO
(604) 732-6540

Ms. Bernice Yip
Chief Financial Officer
(604) 732-6540

Frequently Asked Questions

Who are the new members of Madison Pacific's Board of Directors?

Alistair Duncan, Jr. and Robert Wiens have been appointed as new Board members.

When will the new Board members begin their roles?

Both will officially join the Board effective September 30.

What positions did Mark Elliott and Jonathan Rees hold?

Mark Elliott was a long-time Board member and Chairman of the Audit Committee, while Jonathan Rees served for over six years.

What is Alistair Duncan's background?

He is the President and CEO of viDA Therapeutics and has extensive experience in corporate leadership.

What experience does Robert Wiens bring to the Board?

He has 30 years of executive management experience, including roles in major companies like D-Wave Systems and Arthur Andersen.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading